Imagine that the key to protecting your brain decades from now lies in your vitamin D levels today. That is what a major study published in early April 2026 in the journal Neurology suggests, conducted by researchers at the University of Galway in Ireland. Their conclusions, both promising and cautious, could transform the way we think about Alzheimer's disease prevention.

A study that followed nearly 800 people for 16 years

The protocol of this research is impressive in its rigor and duration. Nearly 800 adults — 793 exactly — were recruited when they were on average 39 years old and showed no signs of dementia. At enrollment, their vitamin D levels were measured by blood test.

Sixteen years later, the same participants underwent advanced brain imaging examinations to quantify two essential biomarkers of Alzheimer's disease: tau protein and beta-amyloid protein. And the results are striking.

"Participants with higher vitamin D levels had significantly lower concentrations of tau protein in the brain regions first affected by Alzheimer's."

— Research team, University of Galway, April 2026

One figure illustrates the scale of the potential problem: 34% of participants had insufficient vitamin D levels at the start of the study, and only 5% were taking supplements. An alarming proportion, given what this deficiency could mean in the long term.

Tau protein: why is it so important in Alzheimer's?

To understand the scope of this discovery, it is necessary to grasp what tau protein is and why it is at the heart of Alzheimer's research.

In a healthy brain, tau proteins play an essential structural role: they stabilize microtubules, the internal "rails" that allow neurons to transport nutrients and circulate information. But in Alzheimer's disease, these proteins deform and clump into neurofibrillary tangles, causing progressive degeneration of neurons.

What the Irish study reveals is that a good vitamin D level at age forty is associated with lower tau accumulation 16 years later, in the areas of the brain specifically targeted at the start of the disease. In contrast, no significant link was found with the other marker, beta-amyloid — a distinction that intrigues researchers and opens new avenues for understanding.

What vitamin D level should you aim for?

In the Galway study, researchers distinguished two groups based on their blood vitamin D levels:

• Sufficient level: above 30 ng/mL (nanograms per milliliter) in the blood
• Low level: below this threshold

It was in this second group that tau protein burden was significantly higher years later. For comparison, values recommended in France by the Haute Autorité de Santé are generally between 20 and 60 ng/mL, with an ideal range around 30 to 50 ng/mL.

Yet, according to available epidemiological data, nearly one in two people in Western countries has insufficient vitamin D levels, particularly in winter, in regions with little sunshine, and among the elderly, those with darker skin, or those spending little time outdoors. A silent public health problem, but of considerable scale.

An established link, but not direct proof of causality

Researchers are the first to highlight the limitations of their work, and it would be inaccurate to over-interpret these results. This is an observational study: it shows an association between vitamin D and tau protein, but does not establish a direct causal link.

In other words, it cannot be claimed today that taking vitamin D supplements will mechanically reduce your risk of developing Alzheimer's. Other factors — genetics, lifestyle, diet, physical exercise, blood pressure — play an equally decisive role in the progression of the disease.

That said, the study strongly supports the need to launch randomized clinical trials to test whether vitamin D supplementation in middle-aged adults could actually reduce tau accumulation and delay the onset of dementia. These trials are now the logical next step.

How to optimize your vitamin D levels daily

While waiting for the results of these future clinical trials, here is what medicine recommends to maintain a satisfactory vitamin D level:

• Sun exposure: 15 to 20 minutes per day on the forearms and face, without sunscreen, between 10 am and 2 pm, are sufficient in summer for effective skin production
• Foods rich in vitamin D: fatty fish (salmon, mackerel, sardine), cod liver, egg yolk, sun-dried mushrooms, fortified milks and yogurts
• Dietary supplements: in cases of proven deficiency or high risk, doctors often prescribe vitamin D3 (cholecalciferol), better absorbed than vitamin D2
• Regular blood tests: a simple 25-OH-vitamin D assay allows you to know your exact level and adjust supplementation accordingly

A major public health challenge for the coming decades

Alzheimer's disease currently affects more than one million people in France and this number is expected to double by 2050 due to the aging population. Finding simple, accessible and inexpensive prevention levers is therefore a strategic challenge for health systems.

The University of Galway study is part of a broader movement of research on modifiable risk factors for dementia. In 2024, a meta-analysis published in The Lancet had identified 14 factors that can be acted upon: hypertension, obesity, diabetes, depression, social isolation... and already, vitamin D deficiency.

What this new study brings is longitudinal confirmation over 16 years of follow-up, linking vitamin D levels to the presence of brain biological markers specific to Alzheimer's. It is not yet sufficient to change official recommendations, but it is an additional piece in a puzzle that is gradually taking shape.

In practice, having your vitamin D level checked at your next blood test is a simple, inexpensive gesture that — in light of this study — perhaps deserves to be systematized from the age of forty. An accessible precaution for everyone, which could prove far more valuable than it appears.